Ignite Creation Date:
2024-05-05 @ 11:35 PM
Last Modification Date:
2024-10-26 @ 10:35 AM
Study NCT ID:
NCT01360073
Status:
COMPLETED
Last Update Posted:
2012-11-14
First Post:
2011-05-24
Brief Title:
Association Between Low Dose Acetylsalicylic Acid ASA and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Association Between Low Dose Acetylsalicylic Acid ASA and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of Patients With Acute Serious Coronary Heart Disease
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to estimate the risk of myocardial infarction MIcoronary death associated with use of monotherapy low dose ASA single antiplatelet as well as concomitant use of monotherapy low dose ASA and proton pump inhibitors PPIs in patients with serious coronary heart disease using two UK primary care databases
Detailed Description:
Number of Anticipated Subjects In case-control analysis 10000-15000 participants
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None